If you have been anywhere near Indian business news lately, you have probably noticed something odd: fertility clinics have suddenly become a sector with opportunity for investors.
A few years back, nobody would have clubbed IVF centres with IPOs and the stock market in the same sentence. But here we are in 2026, and the fertility business in India has turned into one of the more interesting themes for long-term investors.
So in this blog, let us talk about what is happening in this space and which IVF-linked stock is already trading on our exchanges, which big name everyone’s waiting for, and what you should keep in mind before putting money into this theme.
We will try to explain why this sector is growing the way it is, because that context matters more than the stock price on any given day.
What is IVF?
Before we jump into stocks, let us pause for a second and understand what IVF means.
The term IVF stands for In Vitro Fertilisation. An egg and sperm are fertilised outside the body, in a lab, instead of the way it naturally happens inside a woman’s body. “In vitro” translates to “in glass.” So this happens in a small dish, under controlled lab conditions.
Whether it succeeds or not depends on a bunch of things like the woman’s age, which clinic you have chosen, the specific fertility issue, and a lot of couples end up going through more than one cycle before they get a positive result. The journey is emotionally and financially overwhelming.
The Rise of IVF in India
Let us start with the why, because the numbers here are genuinely surprising.
India’s Total Fertility Rate has slipped to around 1.9 births per woman, below the replacement level of 2.1. At the same time, our national infertility rate is near 13%, which translates into roughly 27.5 million Indian couples dealing with fertility issues in some form.
Delayed marriages, career-first lifestyles, stress, pollution, and PCOS cases going up, lifestyle diseases all of this is pushing more couples toward assisted reproduction.
Now what makes it an investment story and not just a health story is that out of the 5-7.5 lakh IVF cycles doctors advise every year, only about 2-2.5 lakh cycles actually get started.
That is a huge gap between demand and what is currently being served, and organised fertility chains are racing to fill it, especially in Tier 2 and Tier 3 cities, where growth rates are running higher than in the metros.
In addition to this fact, the social stigma around infertility treatment is fading fast. A decade ago, couples would not openly talk about going through IVF.
Read Also: Best Healthcare Stocks
Gaudium IVF and Women Health: The Only Listed Company in India
If you go looking for an IVF stock on the NSE or BSE right now, there is only one name that pops up, and that is Gaudium IVF and Women Health Ltd
This is a Bengaluru-headquartered fertility care company that runs on a hub-and-spoke model, a handful of full-fledged IVF hubs supported by smaller satellite centres that feed patients in.
Beyond IVF and ICSI, the company also offers IUI, egg and sperm donation, fertility preservation through cryopreservation, and treatment for conditions like PCOD, PCOS, and endometriosis. The company has laid out expansion plans of roughly 10 new IVF hubs in FY27, 8 more in FY28
On the numbers side, the company’s recent quarterly results showed a healthy jump in both revenue and profit compared to a year earlier.
If you are the type of investor who gets uncomfortable watching a stock move 5-6% in a single session, this one might test your patience.
| Stock Name | Market Capitalisation (cr.) | 52 week high | 52 week low |
|---|---|---|---|
| Gaudium IVF and Women Health | ₹1,102 | ₹163.18 | ₹69.18 |
| 1-M Return | 3-M Return | 1-Y Return |
|---|---|---|
| 36.69% | 21.71% | 0 |
Rainbow Children’s Medicare: A listed Hospital stock, now expanding into fertility
It was founded in 1999 by Ramesh Kancharla, and is headquartered in Hyderabad. Rainbow is not an IVF stock in the way people usually mean it. It is a Hyderabad-based hospital chain that built its name on paediatric and maternity care under the BirthRight brand, running well over 240 facilities across 9+ cities today.
Fertility entered the picture later, when the company started rolling out IVF services alongside its women’s health units. It had 11 hospitals offering IVF as of 2024, and it has been adding more clinics since, including a new one in Bengaluru that opened in May this year.
The stock, listed on both NSE and BSE, has moved between roughly ₹1,084 and ₹1,646 over the past year
| Stock Name | Market Capitalisation (cr.) | 52 week high | 52 week low |
|---|---|---|---|
| Rainbow Children’s Medicare | ₹14,783 | ₹1645.70 | ₹ 1084 |
| 1-M Return | 3-M Return | 1-Y Return |
|---|---|---|
| 1.65% | 17.35% | -10.23% |
Indira IVF: Unlisted but the most talked about
Indira IVF, the country’s largest fertility chain. Founded by Dr Ajay Murdia and now run by CEO Kshitiz Murdia, Indira IVF operates well over 150 centres across India and has been involved in more than 1.75 lakh successful pregnancies since it started. It dominates close to 30% of India’s organised IVF market
Indira IVF’s IPO journey has been anything but smooth. IPO papers were first filed in February 2025 for an IPO expected to value it somewhere around Rs 20,000 crore, but it withdrew soon after.
It refiled through the confidential pre-filing route later that year, but as of early 2026, those draft papers were withdrawn again, and there is still no confirmed listing date.
Read Also: Top Biotech Companies Stocks
Conclusion
The demographic and social drivers behind IVF are real and well documented. But right now, your listed options are limited, mostly small-cap, and come with the volatility tag.
For now, the smart move is probably to track this sector closely, understand the underlying business model of any company you are considering, and size your position accordingly rather than simply picking the stocks.
Frequently Asked Questions (FAQs)
Is Indira IVF listed on the stock market?
Not yet. It has tried to go public twice now. Keep it on your watchlist and wait for an actual listing date.
What is the cost of IVF?
It can get heavy on the pocket. A single cycle usually costs somewhere between ₹1-3 lakh.
Are hospital stocks like Apollo or Rainbow “IVF stocks”?
Not really. They do run fertility centres alongside their main business, but IVF is a small slice of their overall revenue.
Should I invest in unlisted IVF shares being offered online?
Unlisted shares come with liquidity and pricing risks. It is not something to jump into just because someone promises early allotment.
Is the IVF sector a safe long-term investment theme?
The underlying demand is genuinely strong, no doubt about that. But right now, listed options are limited and mostly small-cap, so it comes with volatility.
